Trial
NCT01059448
Safety and Efficacy of AMG 827 in Subjects With RA
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Amgen
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
AMG 827
Why stopped
Lack of efficacy for Brodalumab in Rheumatoid Arthritis (RA)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-28